IRVINE, Calif. - Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN), a biotechnology company with a market capitalization of $284.54 million and a remarkable 170% stock return over the past year according to ...
Tegoprubart has been part of other groundbreaking transplants, including the second-ever pig-to-human heart transplant at the University of Maryland Medical Center in September 2023. It is ...